The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2009Defining Genetic Factors for PD in a Conserved Population
Objective/Rationale:
The identification of genes underlying risk for Parkinson’s disease (PD) helps to further the understanding of this complex disorder, with the discovery of new genes contributing... -
Program-non-specific Funding, 2009Data Repository for Experimental Data
Objective/Rationale:
Synthesizing biomedical data into effective discoveries is greatly hampered by the way science is both reported in research articles and stored in databases. Articles do not... -
Rapid Response Innovation Awards, 2009Development of Potent Conformation-Specific Compounds Directed to Monomeric Alpha-Synuclein
Promising Outcomes of Original Grant:
The goal of our original funded grant was to use our alpha-synuclein assay to identify compounds that prevent conformational change to the fully open form of the... -
Rapid Response Innovation Awards, 2009Evaluation of a Viral Non-coding RNA as a Neuroprotective and Neurorestorative Therapy in Chronic Models of Parkinson's Disease
Promising Outcomes of Original Grant:
Previously, we asked whether a novel viral non-coding RNA (an RNA which does not appear to encode a protein), but with known pro-life functions, could act to... -
MJFF Research Grant, 2009N-Acetylcysteine CSF Levels and Biomarkers in a Pre-clinical Model of PD
Objective/Rationale:
N-Acetylcysteine (NAC) is an orally absorbed compound that supports neuronal synthesis of glutathione, a key neuronal antioxidant. Our objective here is to establish the blood and... -
Rapid Response Innovation Awards, 2009Generation of Dorsal Motor Nucleus (DMN) Specific Pre-clinical Model of Alpha-Synuclein Overexpression to Study Etiology of Autonomic Dysfunction in PD
Promising Outcomes of Original Grant:
According to Braak Staging of PD Pathology, the dorsal motor nucleus (DMN) is one of the earliest brain nuclei that accumulate alpha-Synuclein (aSyn) pathology...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.